TH152483A - Pharmaceutical components that can be given by mouth - Google Patents
Pharmaceutical components that can be given by mouthInfo
- Publication number
- TH152483A TH152483A TH1401004645A TH1401004645A TH152483A TH 152483 A TH152483 A TH 152483A TH 1401004645 A TH1401004645 A TH 1401004645A TH 1401004645 A TH1401004645 A TH 1401004645A TH 152483 A TH152483 A TH 152483A
- Authority
- TH
- Thailand
- Prior art keywords
- alpha
- formula
- chloro
- methyl
- pyrimidine
- Prior art date
Links
- 239000005426 pharmaceutical component Substances 0.000 title claims 3
- 239000000654 additive Substances 0.000 claims abstract 4
- 230000000996 additive Effects 0.000 claims abstract 4
- JBVJFFIKYBQKDR-UHFFFAOYSA-N Cl.ClC=1C(NC(N(C1N1C(CCC1)=N)C)=O)=O Chemical compound Cl.ClC=1C(NC(N(C1N1C(CCC1)=N)C)=O)=O JBVJFFIKYBQKDR-UHFFFAOYSA-N 0.000 claims abstract 3
- 239000004480 active ingredient Substances 0.000 claims abstract 3
- 239000000470 constituent Substances 0.000 claims abstract 3
- 239000003814 drug Substances 0.000 claims abstract 3
- 229940079593 drugs Drugs 0.000 claims abstract 3
- VSQQQLOSPVPRAZ-RRKCRQDMSA-N Trifluridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(C(F)(F)F)=C1 VSQQQLOSPVPRAZ-RRKCRQDMSA-N 0.000 claims abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims abstract 2
- 235000013372 meat Nutrition 0.000 abstract 1
Abstract
DC60 (13/08/57) การประดิษฐ์นี้จัดให้มีองค์ประกอบทางเภสัชกรรมที่สามารถให้ได้โดยการรับประทานที่ประกอบ รวมด้วย FTD และ TPI ซึ่งสามารถให้ได้โดยการรับประทานและมีลักษณะคงตัวแม้ภายใต้สภาวะที่มี ความชื้นสูง องค์ประกอบทางเภสัชกรรมที่สามารถให้ได้โดยการรับประทานซึ่งประกอบรวมด้วย อัลฟา,อัลฟา,อัลฟา- ไตรฟลูออโรไธมิดีน (อัลฟา,อัลฟา,อัลฟา-trifluorothymidine) และ 5-คลอโร-6-(2-อิมิโนไพร์โรลิดีน-1-อิล)เมธิล- 2,4(1H,3H)-ไพริมิดีนไดโอนไฮโดรคลอไรด์ (5-chloro-6-(2-iminopyrrolidine-l-yl)methyl-2,4(1H,3H)- pyrimidine dione hydrochloride) เป็นส่วนประกอบออกฤทธิ์และสารเติมแต่งซึ่งมีความชื้นสัมพัทธ์วิกฤต เท่ากับร้อยละ 85 หรือมากกว่านั้นที่อุณหภูมิ 25 องศาเซลเซียส เป็นส่วนเติมเนื้อยา สิทธิบัตรยา DC60 (13/08/57) This invention provides an oral drugable constituent that includes FTD and TPI, which can be administered orally and is stable even under high humidity conditions. Pharmaceutical constituents that can be administered by mouth include: Alpha, alpha, alpha-trifluorathimidine (Alpha, alpha, alpha-trifluorothymidine) and 5- chloro-6- (2-iminopyrolidine-1-il) methyl - 2,4 (1H. , 3H) - pyrimidine dionhydrochloride. (5-chloro-6- (2-iminopyrrolidine-l-yl) methyl-2,4 (1H, 3H) - pyrimidine dione hydrochloride) is an active ingredient and additive with critical relative humidity. Equal to 85 percent or more at 25 degrees Celsius as a meat additive, drug patent
Claims (1)
Publications (2)
Publication Number | Publication Date |
---|---|
TH152483A true TH152483A (en) | 2016-05-19 |
TH1401004645B TH1401004645B (en) | 2016-05-19 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1123372T1 (en) | ORAL PHARMACEUTICAL COMPOSITION | |
BR112015016930A2 (en) | stabilized pharmaceutical formulations of insulin analogues and / or insulin derivatives | |
BR112015021983A8 (en) | heterocyclic compounds, compositions and uses thereof | |
BR112015000229A2 (en) | stable aqueous formulations of etanercept | |
MX355885B (en) | Oral pharmaceutical composition. | |
DOP2016000047A (en) | COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF THE MEK | |
BR112016011170A8 (en) | derivatives of heteroaryl butanoic acid, their uses, combination and pharmaceutical composition | |
NZ714684A (en) | Stable oral solutions for combined api | |
BR112014014877A2 (en) | 1,5-naphthyridine derivatives and melk inhibitors containing the same | |
EA201890075A1 (en) | INJECTABLE PHARMACEUTICAL COMPOSITIONS LEFAMULIN | |
FR3013985B1 (en) | MOISTURIZING COMPOSITIONS COMPRISING AT LEAST ONE CAESALPINIA SPINOSA EXTRACT WITH AT LEAST VASELIN AND GLYCERIN | |
TH152483A (en) | Pharmaceutical components that can be given by mouth | |
TH152484A (en) | Oral pharmaceutical components | |
TH1901003956A (en) | components for external use | |
TH1901004650A (en) | New heterocyclic compounds, their preparation methods and pharmaceutical compositions which combine them. | |
TH1801007841A (en) | Derivatives of [1, 2, 3] triazolo [4, 5-D] pyrimidine with semipolarity for cannabinoid receptors, type 2. | |
TH1801001807A (en) | An isoindolinone inhibitor of MDM2-P53 interaction with anticancer activity. | |
TH1701000793A (en) | The compound pyrolopyrimidine, which is used as a TLR7 agent. | |
TH166748A (en) | Macro cyclic pyrimidine derivatives | |
TH1801004478A (en) | Steroid Derivative FXR Agent | |
Yiyi | President Li Xiaolin Leads CPAFFC Delegation to Thailand | |
TH165228A (en) | Amide Derivatives for GPR119 Agonists | |
TH1801001086A (en) | Replaced analog nucleoside with a new 6-6 bicyclic aromatic loop for use as a PRMT5 inhibitor. | |
TH1701002063A (en) | Aldosteron Synthes inhibitors | |
TH145247A (en) | Pharmaceutical composition in the form of an oral suspension consisting of fraction sequences, flavonoids and xanthan rubbers. |